Massive italian study aims to uncover what really affects COPD survival

NCT ID NCT06652776

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This large real-world study will follow 10,000 Italian patients with COPD to see how their treatments, flare-ups, and other health conditions affect their risk of death. Researchers will collect data on medications, lung function, and heart problems over time. The goal is to better understand what leads to better or worse outcomes in everyday medical practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this registry could reveal which COPD treatments and care patterns are linked to better survival and fewer hospitalizations, guiding future guidelines.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by differences in patient care or unmeasured factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Luigi Sacco University Hospital, Division of Department of Biomedical and Clinical Sciences, University of Milan

    Milan, Milan, 20157, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.